Loading…
dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats
Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S produci...
Saved in:
Published in: | Nitric oxide 2015-09, Vol.49, p.56-66 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3 |
---|---|
cites | cdi_FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3 |
container_end_page | 66 |
container_issue | |
container_start_page | 56 |
container_title | Nitric oxide |
container_volume | 49 |
creator | Oosterhuis, Nynke R. Frenay, Anne-Roos S. Wesseling, Sebastiaan Snijder, Pauline M. Slaats, Gisela G. Yazdani, Saleh Fernandez, Bernadette O. Feelisch, Martin Giles, Rachel H. Verhaar, Marianne C. Joles, Jaap A. van Goor, Harry |
description | Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S producing enzyme cystathionine γ-lyase (CSE) by d,l-propargylglycine (PAG). We hypothesized that blocking H2S production ameliorates Angiotensin II (AngII)-induced hypertension and renal injury in a rodent model. Effects of concomitant administration of PAG or saline were therefore studied in healthy (CON) and AngII hypertensive rats.
In CON rats, PAG did not affect systolic blood pressure (SBP), but slightly increased proteinuria. In AngII rats PAG reduced SBP, proteinuria and plasma creatinine (180 ± 12 vs. 211 ± 19 mmHg; 66 ± 35 vs. 346 ± 92 mg/24 h; 24 ± 6 vs. 47 ± 15 μmol/L, respectively; p |
doi_str_mv | 10.1016/j.niox.2015.07.001 |
format | article |
fullrecord | <record><control><sourceid>elsevier_wagen</sourceid><recordid>TN_cdi_wageningen_narcis_oai_library_wur_nl_wurpubs_501590</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1089860315300021</els_id><sourcerecordid>S1089860315300021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi1UREvhBThUeYGEsZ14Y8SlqgqsVIkLnC3_mQRvUyeyky55exxtu0cuntH4933SzEfIJwoVBSo-H6rgx78VA9pUsKsA6BtyRaGVZSsovTj3wC_J-5QOAFDzVrwjl0xQybjgV-TZDeUUx0nHfh36YbU-YBHRLRZTYYZxdMUUMaUlYqGDy19BD4UPhyWuhVnm3NqIOmX60buAa3FE3__Z5pnv_ThjSD6U-32edEvCbKHn9IG87fSQ8ONLvSa_v93_uvtRPvz8vr-7fSht3dC55LgzQrdMNNI0dddJLR1C27AOsEa9M1JQoyXnrNWCcm6kcbRmwJmTzrqOX5MvJ9-j7jH4kB8VdLQ-qVF7NXgTdVzVcYkqDFuZFpNUky8qIYvZSWzjmFLETk3RP208BbUloA5qS0BtCSjYqZxAFt2cRNnpCd1Z8nryDHw9AZj3fvYYVbIeg0XnI9pZudH_z_8fqKecVw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats</title><source>Elsevier</source><creator>Oosterhuis, Nynke R. ; Frenay, Anne-Roos S. ; Wesseling, Sebastiaan ; Snijder, Pauline M. ; Slaats, Gisela G. ; Yazdani, Saleh ; Fernandez, Bernadette O. ; Feelisch, Martin ; Giles, Rachel H. ; Verhaar, Marianne C. ; Joles, Jaap A. ; van Goor, Harry</creator><creatorcontrib>Oosterhuis, Nynke R. ; Frenay, Anne-Roos S. ; Wesseling, Sebastiaan ; Snijder, Pauline M. ; Slaats, Gisela G. ; Yazdani, Saleh ; Fernandez, Bernadette O. ; Feelisch, Martin ; Giles, Rachel H. ; Verhaar, Marianne C. ; Joles, Jaap A. ; van Goor, Harry</creatorcontrib><description>Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S producing enzyme cystathionine γ-lyase (CSE) by d,l-propargylglycine (PAG). We hypothesized that blocking H2S production ameliorates Angiotensin II (AngII)-induced hypertension and renal injury in a rodent model. Effects of concomitant administration of PAG or saline were therefore studied in healthy (CON) and AngII hypertensive rats.
In CON rats, PAG did not affect systolic blood pressure (SBP), but slightly increased proteinuria. In AngII rats PAG reduced SBP, proteinuria and plasma creatinine (180 ± 12 vs. 211 ± 19 mmHg; 66 ± 35 vs. 346 ± 92 mg/24 h; 24 ± 6 vs. 47 ± 15 μmol/L, respectively; p < 0.01). Unexpectedly, kidney to body weight ratio was increased in all groups by PAG (p < 0.05). Renal injury induced by AngII was reduced by PAG (p < 0.001). HO-1 gene expression was increased by PAG alone (p < 0.05). PAG increased inner cortical tubular cell proliferation after 1 week and decreased outer cortical tubular nucleus number/field after 4 weeks. In vitro proximal tubular cell size increased after exposure to PAG.
In summary, blocking H2S production with PAG reduced SBP and renal injury in AngII infused rats. Independent of the cardiovascular and renal effects, PAG increased HO-1 gene expression and kidney weight. PAG alone increased tubular cell size and proliferation in-vivo and in-vitro. Our results are indicative of a complex interplay of gasotransmitter signaling/action of mutually compensatory nature in the kidney.
•dl-propargylglycine (PAG) abolished H2S production in the kidney.•PAG reduced systolic blood pressure and renal injury in angiotensin II-infused rats.•Independent of kidney function PAG increased kidney weight.•PAG increased tubular cell size and proliferation.</description><identifier>ISSN: 1089-8603</identifier><identifier>EISSN: 1089-8611</identifier><identifier>DOI: 10.1016/j.niox.2015.07.001</identifier><identifier>PMID: 26192363</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute Kidney Injury - chemically induced ; Acute Kidney Injury - metabolism ; Alkynes - administration & dosage ; Alkynes - pharmacology ; Angiotensin II - adverse effects ; Angiotensin-II ; Animals ; Blood Pressure - drug effects ; Cell Proliferation ; DL-Propargylglycine ; Glycine - administration & dosage ; Glycine - analogs & derivatives ; Glycine - pharmacology ; Heme Oxygenase-1 - metabolism ; Hydrogen sulfide ; Hydrogen Sulfide - metabolism ; Hypertension ; Kidney - drug effects ; Kidney - pathology ; Kidney weight ; Male ; Nitric Oxide ; Organ Size ; Proteinuria ; Rats ; Rats, Sprague-Dawley</subject><ispartof>Nitric oxide, 2015-09, Vol.49, p.56-66</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><rights>Wageningen University & Research</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3</citedby><cites>FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26192363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oosterhuis, Nynke R.</creatorcontrib><creatorcontrib>Frenay, Anne-Roos S.</creatorcontrib><creatorcontrib>Wesseling, Sebastiaan</creatorcontrib><creatorcontrib>Snijder, Pauline M.</creatorcontrib><creatorcontrib>Slaats, Gisela G.</creatorcontrib><creatorcontrib>Yazdani, Saleh</creatorcontrib><creatorcontrib>Fernandez, Bernadette O.</creatorcontrib><creatorcontrib>Feelisch, Martin</creatorcontrib><creatorcontrib>Giles, Rachel H.</creatorcontrib><creatorcontrib>Verhaar, Marianne C.</creatorcontrib><creatorcontrib>Joles, Jaap A.</creatorcontrib><creatorcontrib>van Goor, Harry</creatorcontrib><title>dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats</title><title>Nitric oxide</title><addtitle>Nitric Oxide</addtitle><description>Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S producing enzyme cystathionine γ-lyase (CSE) by d,l-propargylglycine (PAG). We hypothesized that blocking H2S production ameliorates Angiotensin II (AngII)-induced hypertension and renal injury in a rodent model. Effects of concomitant administration of PAG or saline were therefore studied in healthy (CON) and AngII hypertensive rats.
In CON rats, PAG did not affect systolic blood pressure (SBP), but slightly increased proteinuria. In AngII rats PAG reduced SBP, proteinuria and plasma creatinine (180 ± 12 vs. 211 ± 19 mmHg; 66 ± 35 vs. 346 ± 92 mg/24 h; 24 ± 6 vs. 47 ± 15 μmol/L, respectively; p < 0.01). Unexpectedly, kidney to body weight ratio was increased in all groups by PAG (p < 0.05). Renal injury induced by AngII was reduced by PAG (p < 0.001). HO-1 gene expression was increased by PAG alone (p < 0.05). PAG increased inner cortical tubular cell proliferation after 1 week and decreased outer cortical tubular nucleus number/field after 4 weeks. In vitro proximal tubular cell size increased after exposure to PAG.
In summary, blocking H2S production with PAG reduced SBP and renal injury in AngII infused rats. Independent of the cardiovascular and renal effects, PAG increased HO-1 gene expression and kidney weight. PAG alone increased tubular cell size and proliferation in-vivo and in-vitro. Our results are indicative of a complex interplay of gasotransmitter signaling/action of mutually compensatory nature in the kidney.
•dl-propargylglycine (PAG) abolished H2S production in the kidney.•PAG reduced systolic blood pressure and renal injury in angiotensin II-infused rats.•Independent of kidney function PAG increased kidney weight.•PAG increased tubular cell size and proliferation.</description><subject>Acute Kidney Injury - chemically induced</subject><subject>Acute Kidney Injury - metabolism</subject><subject>Alkynes - administration & dosage</subject><subject>Alkynes - pharmacology</subject><subject>Angiotensin II - adverse effects</subject><subject>Angiotensin-II</subject><subject>Animals</subject><subject>Blood Pressure - drug effects</subject><subject>Cell Proliferation</subject><subject>DL-Propargylglycine</subject><subject>Glycine - administration & dosage</subject><subject>Glycine - analogs & derivatives</subject><subject>Glycine - pharmacology</subject><subject>Heme Oxygenase-1 - metabolism</subject><subject>Hydrogen sulfide</subject><subject>Hydrogen Sulfide - metabolism</subject><subject>Hypertension</subject><subject>Kidney - drug effects</subject><subject>Kidney - pathology</subject><subject>Kidney weight</subject><subject>Male</subject><subject>Nitric Oxide</subject><subject>Organ Size</subject><subject>Proteinuria</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><issn>1089-8603</issn><issn>1089-8611</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxi1UREvhBThUeYGEsZ14Y8SlqgqsVIkLnC3_mQRvUyeyky55exxtu0cuntH4933SzEfIJwoVBSo-H6rgx78VA9pUsKsA6BtyRaGVZSsovTj3wC_J-5QOAFDzVrwjl0xQybjgV-TZDeUUx0nHfh36YbU-YBHRLRZTYYZxdMUUMaUlYqGDy19BD4UPhyWuhVnm3NqIOmX60buAa3FE3__Z5pnv_ThjSD6U-32edEvCbKHn9IG87fSQ8ONLvSa_v93_uvtRPvz8vr-7fSht3dC55LgzQrdMNNI0dddJLR1C27AOsEa9M1JQoyXnrNWCcm6kcbRmwJmTzrqOX5MvJ9-j7jH4kB8VdLQ-qVF7NXgTdVzVcYkqDFuZFpNUky8qIYvZSWzjmFLETk3RP208BbUloA5qS0BtCSjYqZxAFt2cRNnpCd1Z8nryDHw9AZj3fvYYVbIeg0XnI9pZudH_z_8fqKecVw</recordid><startdate>20150915</startdate><enddate>20150915</enddate><creator>Oosterhuis, Nynke R.</creator><creator>Frenay, Anne-Roos S.</creator><creator>Wesseling, Sebastiaan</creator><creator>Snijder, Pauline M.</creator><creator>Slaats, Gisela G.</creator><creator>Yazdani, Saleh</creator><creator>Fernandez, Bernadette O.</creator><creator>Feelisch, Martin</creator><creator>Giles, Rachel H.</creator><creator>Verhaar, Marianne C.</creator><creator>Joles, Jaap A.</creator><creator>van Goor, Harry</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>QVL</scope></search><sort><creationdate>20150915</creationdate><title>dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats</title><author>Oosterhuis, Nynke R. ; Frenay, Anne-Roos S. ; Wesseling, Sebastiaan ; Snijder, Pauline M. ; Slaats, Gisela G. ; Yazdani, Saleh ; Fernandez, Bernadette O. ; Feelisch, Martin ; Giles, Rachel H. ; Verhaar, Marianne C. ; Joles, Jaap A. ; van Goor, Harry</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acute Kidney Injury - chemically induced</topic><topic>Acute Kidney Injury - metabolism</topic><topic>Alkynes - administration & dosage</topic><topic>Alkynes - pharmacology</topic><topic>Angiotensin II - adverse effects</topic><topic>Angiotensin-II</topic><topic>Animals</topic><topic>Blood Pressure - drug effects</topic><topic>Cell Proliferation</topic><topic>DL-Propargylglycine</topic><topic>Glycine - administration & dosage</topic><topic>Glycine - analogs & derivatives</topic><topic>Glycine - pharmacology</topic><topic>Heme Oxygenase-1 - metabolism</topic><topic>Hydrogen sulfide</topic><topic>Hydrogen Sulfide - metabolism</topic><topic>Hypertension</topic><topic>Kidney - drug effects</topic><topic>Kidney - pathology</topic><topic>Kidney weight</topic><topic>Male</topic><topic>Nitric Oxide</topic><topic>Organ Size</topic><topic>Proteinuria</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oosterhuis, Nynke R.</creatorcontrib><creatorcontrib>Frenay, Anne-Roos S.</creatorcontrib><creatorcontrib>Wesseling, Sebastiaan</creatorcontrib><creatorcontrib>Snijder, Pauline M.</creatorcontrib><creatorcontrib>Slaats, Gisela G.</creatorcontrib><creatorcontrib>Yazdani, Saleh</creatorcontrib><creatorcontrib>Fernandez, Bernadette O.</creatorcontrib><creatorcontrib>Feelisch, Martin</creatorcontrib><creatorcontrib>Giles, Rachel H.</creatorcontrib><creatorcontrib>Verhaar, Marianne C.</creatorcontrib><creatorcontrib>Joles, Jaap A.</creatorcontrib><creatorcontrib>van Goor, Harry</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>NARCIS:Publications</collection><jtitle>Nitric oxide</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oosterhuis, Nynke R.</au><au>Frenay, Anne-Roos S.</au><au>Wesseling, Sebastiaan</au><au>Snijder, Pauline M.</au><au>Slaats, Gisela G.</au><au>Yazdani, Saleh</au><au>Fernandez, Bernadette O.</au><au>Feelisch, Martin</au><au>Giles, Rachel H.</au><au>Verhaar, Marianne C.</au><au>Joles, Jaap A.</au><au>van Goor, Harry</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats</atitle><jtitle>Nitric oxide</jtitle><addtitle>Nitric Oxide</addtitle><date>2015-09-15</date><risdate>2015</risdate><volume>49</volume><spage>56</spage><epage>66</epage><pages>56-66</pages><issn>1089-8603</issn><eissn>1089-8611</eissn><abstract>Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S producing enzyme cystathionine γ-lyase (CSE) by d,l-propargylglycine (PAG). We hypothesized that blocking H2S production ameliorates Angiotensin II (AngII)-induced hypertension and renal injury in a rodent model. Effects of concomitant administration of PAG or saline were therefore studied in healthy (CON) and AngII hypertensive rats.
In CON rats, PAG did not affect systolic blood pressure (SBP), but slightly increased proteinuria. In AngII rats PAG reduced SBP, proteinuria and plasma creatinine (180 ± 12 vs. 211 ± 19 mmHg; 66 ± 35 vs. 346 ± 92 mg/24 h; 24 ± 6 vs. 47 ± 15 μmol/L, respectively; p < 0.01). Unexpectedly, kidney to body weight ratio was increased in all groups by PAG (p < 0.05). Renal injury induced by AngII was reduced by PAG (p < 0.001). HO-1 gene expression was increased by PAG alone (p < 0.05). PAG increased inner cortical tubular cell proliferation after 1 week and decreased outer cortical tubular nucleus number/field after 4 weeks. In vitro proximal tubular cell size increased after exposure to PAG.
In summary, blocking H2S production with PAG reduced SBP and renal injury in AngII infused rats. Independent of the cardiovascular and renal effects, PAG increased HO-1 gene expression and kidney weight. PAG alone increased tubular cell size and proliferation in-vivo and in-vitro. Our results are indicative of a complex interplay of gasotransmitter signaling/action of mutually compensatory nature in the kidney.
•dl-propargylglycine (PAG) abolished H2S production in the kidney.•PAG reduced systolic blood pressure and renal injury in angiotensin II-infused rats.•Independent of kidney function PAG increased kidney weight.•PAG increased tubular cell size and proliferation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26192363</pmid><doi>10.1016/j.niox.2015.07.001</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1089-8603 |
ispartof | Nitric oxide, 2015-09, Vol.49, p.56-66 |
issn | 1089-8603 1089-8611 |
language | eng |
recordid | cdi_wageningen_narcis_oai_library_wur_nl_wurpubs_501590 |
source | Elsevier |
subjects | Acute Kidney Injury - chemically induced Acute Kidney Injury - metabolism Alkynes - administration & dosage Alkynes - pharmacology Angiotensin II - adverse effects Angiotensin-II Animals Blood Pressure - drug effects Cell Proliferation DL-Propargylglycine Glycine - administration & dosage Glycine - analogs & derivatives Glycine - pharmacology Heme Oxygenase-1 - metabolism Hydrogen sulfide Hydrogen Sulfide - metabolism Hypertension Kidney - drug effects Kidney - pathology Kidney weight Male Nitric Oxide Organ Size Proteinuria Rats Rats, Sprague-Dawley |
title | dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A58%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_wagen&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=dl-propargylglycine%20reduces%20blood%20pressure%20and%20renal%20injury%20but%20increases%20kidney%20weight%20in%20angiotensin-II%20infused%20rats&rft.jtitle=Nitric%20oxide&rft.au=Oosterhuis,%20Nynke%20R.&rft.date=2015-09-15&rft.volume=49&rft.spage=56&rft.epage=66&rft.pages=56-66&rft.issn=1089-8603&rft.eissn=1089-8611&rft_id=info:doi/10.1016/j.niox.2015.07.001&rft_dat=%3Celsevier_wagen%3ES1089860315300021%3C/elsevier_wagen%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/26192363&rfr_iscdi=true |